IMRN Immuron Limited
$0.93▲ +1.11%
Healthcare
Other
After hours
$0.93▼ -0.55%
Oct 27, 4:04 PM ET
Volume 6.7K
Avg Volume (10D) 39.0K
Key Metrics & Fundamentals
Market Cap
$7.51M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.68 - 2.21
% vs 50 MA
-20.52%
% vs 200 MA
-8.62%
RSI-14
35.0
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.49
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Presenting on Emerging Growth Conference 97 Day 1 on October 28; Register to live stream
GlobeNewswire · Oct 27, 2026 7:00 AM ET
Immuron continued quarterly sales growth
GlobeNewswire · Oct 27, 2026 6:00 AM ET
Immuron CEO, Steven Lydeamore presentation at Emerging Growth Conference
GlobeNewswire · Oct 22, 2026 6:27 PM ET
Travelan® Phase 2 Study Results Published
GlobeNewswire · Oct 13, 2026 6:00 AM ET
Sector Update: Healthcare Stocks Decline Late Afternoon
MT Newswires · Sep 4, 2026 3:48 PM ET
Immuron Signs Exclusive US Distribution Deal for Digestive-Health Product PROIBS
MT Newswires · Sep 4, 2026 1:51 PM ET
Sector Update: Healthcare Stocks Decline Friday Afternoon
MT Newswires · Sep 4, 2026 1:41 PM ET
Top Midday Gainers
MT Newswires · Sep 4, 2026 1:16 PM ET
IMRN Stock Skyrockets 60%, Heads For Best Day In Over 2 Years – What’s Driving The Super Rally Today?
Stocktwits · Sep 4, 2026 10:50 AM ET
Immuron Plans U.S. PROIBS Launch Under Exclusive Distribution Agreement
InvestorsHub · Sep 4, 2026 9:53 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.